Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Brian Concannon. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Brian Concannon zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:CNMD / CONMED Corporation | Director | 10 116 |
| US:HAE / Haemonetics Corporation | President & CEO, Director | 39 414 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Brian Concannon. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera CNMD / CONMED Corporation – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w CNMD / CONMED Corporation. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera CNMD / CONMED Corporation — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w CNMD / CONMED Corporation. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Zakupy insidera HAE / Haemonetics Corporation – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w CNMD / CONMED Corporation. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera HAE / Haemonetics Corporation — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w CNMD / CONMED Corporation. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Brian Concannon ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 479 | 10 116 | 4,97 | ||||
| 2024-06-05 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 302 | 9 637 | 3,24 | ||||
| 2023-06-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -812 | 9 335 | -8,00 | 129,01 | -104 756 | 1 204 308 | |
| 2023-06-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 335 | 10 147 | 3,41 | ||||
| 2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -2 072 | 9 812 | -17,44 | 125,00 | -259 000 | 1 226 500 | |
| 2022-06-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 812 | 11 884 | 7,33 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Sars (Stock Appreciation Rights) |
M - Exercise | -1 000 | 0 | -100,00 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Sars (Stock Appreciation Rights) |
M - Exercise | -1 000 | 0 | -100,00 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Sars (Stock Appreciation Rights) |
M - Exercise | -1 000 | 0 | -100,00 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | -1 843 | 0 | -100,00 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | -2 165 | 0 | -100,00 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | -2 549 | 0 | -100,00 | ||||
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -401 | 11 072 | -3,50 | 139,03 | -55 751 | 1 539 340 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 000 | 11 473 | 9,55 | 55,70 | 55 700 | 639 046 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -286 | 10 473 | -2,66 | 139,03 | -39 763 | 1 456 061 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 000 | 10 759 | 10,25 | 39,64 | 39 640 | 426 487 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -241 | 9 759 | -2,41 | 139,03 | -33 506 | 1 356 794 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 000 | 10 000 | 11,11 | 33,43 | 33 430 | 334 300 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -1 843 | 9 000 | -17,00 | 135,06 | -248 916 | 1 215 540 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 843 | 10 843 | 20,48 | 73,94 | 136 271 | 801 731 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -2 165 | 9 000 | -19,39 | 135,08 | -292 448 | 1 215 720 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 2 165 | 11 165 | 24,06 | 79,94 | 173 070 | 892 530 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -2 549 | 9 000 | -22,07 | 135,08 | -344 319 | 1 215 720 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 2 549 | 11 549 | 28,32 | 69,03 | 175 957 | 797 227 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -200 | 9 000 | -2,17 | 137,91 | -27 582 | 1 241 190 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -4 200 | 9 200 | -31,34 | 136,96 | -575 232 | 1 260 032 | |
| 2022-02-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -2 027 | 13 400 | -13,14 | 135,09 | -273 827 | 1 810 206 | |
| 2021-06-03 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
A - Award | 865 | 865 | |||||
| 2021-06-03 |
|
4 | CNMD |
CONMED Corp
Rsus (restricted Stock Units) |
A - Award | 812 | 812 | |||||
| 2021-06-03 |
|
4 | CNMD |
CONMED Corp
Rsus (restricted Stock Units) |
M - Exercise | -1 521 | 0 | -100,00 | ||||
| 2021-06-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 521 | 15 427 | 10,94 | ||||
| 2020-09-14 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -3 036 | 13 906 | -17,92 | 89,31 | -271 145 | 1 241 945 | |
| 2020-06-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 1 843 | 1 843 | |||||
| 2020-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 1 521 | 1 521 | |||||
| 2020-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -1 407 | 0 | -100,00 | ||||
| 2020-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 407 | 16 942 | 9,06 | ||||
| 2019-06-04 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 2 165 | 2 165 | |||||
| 2019-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 1 407 | 1 407 | |||||
| 2019-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -1 629 | 0 | -100,00 | ||||
| 2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 629 | 15 535 | 11,71 | ||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 2 549 | 2 549 | |||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 1 629 | 1 629 | |||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -2 167 | 0 | -100,00 | ||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 167 | 13 906 | 18,46 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 3 669 | 3 669 | 51,90 | 190 421 | 190 421 | ||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 2 167 | 2 167 | |||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -2 739 | 0 | -100,00 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 739 | 11 739 | 30,43 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 2 739 | 2 739 | |||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 5 396 | 5 396 | |||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -3 000 | 0 | -100,00 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 000 | 9 000 | 50,00 | ||||
| 2015-09-16 |
|
4 | HAE |
HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy) |
M - Exercise | -6 569 | 39 414 | -14,29 | ||||
| 2015-09-16 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -6 569 | 147 040 | -4,28 | 35,15 | -230 900 | 5 168 456 |
| 2015-09-16 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 6 569 | 153 609 | 4,47 | 27,69 | 181 896 | 4 253 433 |
| 2015-09-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 4 761 | -50,02 | 35,63 | -169 792 | 169 650 |
| 2015-09-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 35,63 | -169 792 | 5 239 506 |
| 2015-09-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-08-18 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -6 569 | 45 983 | -12,50 | 39,28 | -258 019 | 1 806 134 |
| 2015-08-18 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -6 569 | 147 040 | -4,28 | 39,28 | -258 019 | 5 775 481 |
| 2015-08-18 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 6 569 | 153 609 | 4,47 | 27,68 | 181 863 | 4 252 665 |
| 2015-08-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 9 526 | -33,34 | 39,91 | -190 189 | 380 219 |
| 2015-08-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 39,91 | -190 189 | 5 868 925 |
| 2015-08-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-07-16 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -6 569 | 52 552 | -11,11 | 39,59 | -260 092 | 2 080 733 |
| 2015-07-16 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -6 569 | 147 040 | -4,28 | 39,59 | -260 092 | 5 821 872 |
| 2015-07-16 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 6 569 | 153 609 | 4,47 | 27,68 | 181 863 | 4 252 665 |
| 2015-07-06 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 14 291 | -25,01 | 41,28 | -196 711 | 589 968 |
| 2015-07-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 41,28 | -196 711 | 6 070 179 |
| 2015-07-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-07-02 |
|
4/A | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 1 000 | 1 000 | |||||
| 2015-07-02 |
|
4/A | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 3 000 | 3 000 | |||||
| 2015-06-17 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -6 569 | 59 121 | -10,00 | 42,51 | -279 221 | 2 512 991 |
| 2015-06-17 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -6 569 | 147 040 | -4,28 | 42,51 | -279 221 | 6 250 068 |
| 2015-06-17 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 6 569 | 153 609 | 4,47 | 27,68 | 181 863 | 4 252 665 |
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -3 000 | 0 | -100,00 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 000 | 6 000 | 100,00 | ||||
| 2015-06-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 19 056 | -20,00 | 41,39 | -197 214 | 788 692 |
| 2015-06-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 41,39 | -197 214 | 6 085 706 |
| 2015-06-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-05-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 23 821 | -16,67 | 40,74 | -194 139 | 970 532 |
| 2015-05-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 40,74 | -194 139 | 5 990 807 |
| 2015-05-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-04-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 28 586 | -14,29 | 44,51 | -212 076 | 1 272 280 |
| 2015-04-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 44,51 | -212 076 | 6 544 324 |
| 2015-04-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-03-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 33 351 | -12,50 | 44,41 | -211 617 | 1 481 145 |
| 2015-03-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 44,41 | -211 617 | 6 530 164 |
| 2015-03-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-02-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 38 116 | -11,11 | 39,15 | -186 530 | 1 492 085 |
| 2015-02-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 39,15 | -186 530 | 5 756 013 |
| 2015-02-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2015-01-06 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 42 881 | -10,00 | 37,20 | -177 252 | 1 595 117 |
| 2015-01-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 37,20 | -177 252 | 5 469 697 |
| 2015-01-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2014-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 47 646 | -9,09 | 36,72 | -174 979 | 1 749 647 |
| 2014-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 36,72 | -174 979 | 5 399 573 |
| 2014-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2014-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 765 | 52 411 | -8,33 | 35,86 | -170 888 | 1 879 621 |
| 2014-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 765 | 147 040 | -3,14 | 35,86 | -170 888 | 5 273 310 |
| 2014-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 765 | 151 805 | 3,24 | 27,28 | 129 965 | 4 140 481 |
| 2014-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -3 215 | 147 040 | -2,14 | 36,22 | -116 447 | 5 325 789 |
| 2014-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -2 794 | 150 255 | -1,83 | 36,22 | -101 199 | 5 442 236 |
| 2014-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -2 188 | 153 049 | -1,41 | 35,92 | -78 593 | 5 497 520 |
| 2014-10-24 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -2 048 | 155 237 | -1,30 | 35,44 | -72 581 | 5 501 599 |
| 2014-10-24 |
|
4 | HAE |
HAEMONETICS CORP
Performance Shares |
A - Award | 53 956 | 103 956 | 107,91 | ||||
| 2014-10-24 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 119 731 | 119 731 | |||||
| 2014-10-24 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
A - Award | 26 978 | 157 285 | 20,70 | ||||
| 2014-09-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 1 000 | 1 000 | |||||
| 2014-09-15 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 3 000 | 3 000 | |||||
| 2014-08-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 380 | 0 | -100,00 | 35,27 | -154 465 | |
| 2014-08-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 380 | 130 307 | -3,25 | 35,27 | -154 465 | 4 595 407 |
| 2014-08-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 380 | 134 687 | 3,36 | 25,54 | 111 843 | 3 439 233 |
| 2014-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 4 380 | -51,22 | 35,83 | -164 798 | 156 916 |
| 2014-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 35,83 | -164 798 | 4 668 326 |
| 2014-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2014-06-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 8 980 | -33,87 | 33,54 | -154 300 | 301 221 |
| 2014-06-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 33,54 | -154 300 | 4 370 953 |
| 2014-06-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -3 000 | 0 | -100,00 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 000 | 3 000 | |||||
| 2014-05-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 13 580 | -25,30 | 30,01 | -138 042 | 407 524 |
| 2014-05-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 30,01 | -138 042 | 3 910 396 |
| 2014-05-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2014-04-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 18 180 | -20,19 | 32,71 | -150 466 | 594 666 |
| 2014-04-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 32,71 | -150 466 | 4 262 329 |
| 2014-04-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2014-03-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 22 780 | -16,80 | 36,36 | -167 235 | 828 178 |
| 2014-03-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 36,36 | -167 235 | 4 737 376 |
| 2014-03-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2014-02-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 27 380 | -14,38 | 37,63 | -173 080 | 1 030 203 |
| 2014-02-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 0 | -100,00 | 37,64 | -112 916 | |
| 2014-02-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 130 307 | -2,25 | 37,64 | -112 916 | 4 904 586 |
| 2014-02-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 133 307 | 2,30 | 13,05 | 39 158 | 1 739 990 |
| 2014-02-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 37,63 | -173 080 | 4 902 944 |
| 2014-02-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2014-01-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 31 980 | -12,58 | 41,55 | -191 141 | 1 328 843 |
| 2014-01-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 3 000 | -50,00 | 41,63 | -124 888 | 124 888 |
| 2014-01-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 130 307 | -2,25 | 41,63 | -124 888 | 5 424 615 |
| 2014-01-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 133 307 | 2,30 | 13,05 | 39 158 | 1 739 990 |
| 2014-01-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 41,55 | -191 141 | 5 414 556 |
| 2014-01-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2013-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 36 580 | -11,17 | 42,29 | -194 548 | 1 547 078 |
| 2013-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 6 000 | -33,33 | 42,33 | -126 980 | 253 961 |
| 2013-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 130 307 | -2,25 | 42,33 | -126 980 | 5 515 478 |
| 2013-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 133 307 | 2,30 | 13,05 | 39 158 | 1 739 990 |
| 2013-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 42,29 | -194 548 | 5 511 074 |
| 2013-12-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2013-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 41 180 | -10,05 | 39,96 | -183 806 | 1 645 462 |
| 2013-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 9 000 | -25,00 | 39,96 | -119 881 | 359 644 |
| 2013-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 130 307 | -2,25 | 39,96 | -119 881 | 5 207 120 |
| 2013-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 133 307 | 2,30 | 13,05 | 39 158 | 1 739 990 |
| 2013-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -4 600 | 130 307 | -3,41 | 39,96 | -183 806 | 5 206 781 |
| 2013-11-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 4 600 | 134 907 | 3,53 | 25,54 | 117 461 | 3 444 850 |
| 2013-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -2 975 | 130 307 | -2,23 | 39,55 | -117 666 | 5 153 863 |
| 2013-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -3 318 | 133 282 | -2,43 | 39,55 | -131 233 | 5 271 530 |
| 2013-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -1 211 | 136 600 | -0,88 | 39,55 | -47 897 | 5 402 735 |
| 2013-10-29 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -3 191 | 137 811 | -2,26 | 41,09 | -131 118 | 5 662 654 |
| 2013-10-25 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 234 899 | 234 899 | |||||
| 2013-10-25 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
A - Award | 25 204 | 141 002 | 21,77 | ||||
| 2013-10-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 12 000 | -20,00 | 39,88 | -119 647 | 478 589 |
| 2013-10-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 115 798 | -2,53 | 39,88 | -119 647 | 4 618 302 |
| 2013-10-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 118 798 | 2,59 | 13,05 | 39 158 | 1 550 611 |
| 2013-09-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | -3 000 | 15 000 | -16,67 | 39,87 | -119 609 | 598 046 | |
| 2013-09-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | 39,87 | -398 676 | ||
| 2013-09-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 115 798 | -7,95 | 39,87 | -398 676 | 4 616 588 |
| 2013-09-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | 10 000 | 125 798 | 8,64 | 11,32 | 113 175 | 1 423 719 | |
| 2013-09-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 115 798 | -2,53 | 39,87 | -119 609 | 4 616 832 |
| 2013-09-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | 3 000 | 118 798 | 2,59 | 13,05 | 39 158 | 1 550 611 | |
| 2013-08-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | -3 000 | 18 000 | -14,29 | 42,30 | -126 900 | 761 400 | |
| 2013-08-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | -10 000 | 10 000 | -50,00 | 42,23 | -422 300 | 422 300 | |
| 2013-08-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 115 798 | -7,95 | 42,22 | -422 244 | 4 889 501 |
| 2013-08-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 125 798 | 8,64 | 11,32 | 113 175 | 1 423 719 |
| 2013-08-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 115 798 | -2,53 | 42,30 | -126 900 | 4 898 255 |
| 2013-08-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 118 798 | 2,59 | 13,05 | 39 158 | 1 550 611 |
| 2013-07-30 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 1 000 | 1 000 | 33,43 | 33 430 | 33 430 | ||
| 2013-07-30 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 3 000 | 3 000 | |||||
| 2013-07-26 |
|
4 | HAE |
HAEMONETICS CORP
Performance Shares |
A - Award | 50 000 | 50 000 | |||||
| 2013-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 21 000 | -12,50 | |||
| 2013-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 20 000 | -33,33 | |||
| 2013-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 115 798 | -7,95 | 41,88 | -418 820 | 4 849 852 |
| 2013-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 125 798 | 8,64 | 11,32 | 113 175 | 1 423 719 |
| 2013-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 115 798 | -2,53 | 41,84 | -125 522 | 4 845 046 |
| 2013-07-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 118 798 | 2,59 | 13,05 | 39 158 | 1 550 611 |
| 2013-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 24 000 | -11,11 | |||
| 2013-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 30 000 | -25,00 | |||
| 2013-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 115 798 | -7,95 | 41,14 | -411 436 | 4 764 347 |
| 2013-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 125 798 | 8,64 | 11,32 | 113 175 | 1 423 719 |
| 2013-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 115 798 | -2,53 | 41,17 | -123 519 | 4 767 763 |
| 2013-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 118 798 | 2,59 | 13,05 | 39 158 | 1 550 611 |
| 2013-05-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 27 000 | -10,00 | |||
| 2013-05-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 40 000 | -20,00 | |||
| 2013-05-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 115 798 | -7,95 | 38,67 | -386 742 | 4 478 395 |
| 2013-05-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 125 798 | 8,64 | 11,32 | 113 175 | 1 423 719 |
| 2013-05-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 115 798 | -2,53 | 38,62 | -115 862 | 4 472 200 |
| 2013-05-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 118 798 | 2,59 | 13,05 | 39 158 | 1 550 611 |
| 2013-04-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -488 | 115 798 | -0,42 | 41,83 | -20 413 | 4 843 830 |
| 2013-04-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -288 | 0 | -100,00 | |||
| 2013-04-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 50 000 | -16,67 | |||
| 2013-04-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 116 286 | -7,92 | 41,94 | -419 393 | 4 876 953 |
| 2013-04-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 126 286 | 8,60 | 11,32 | 113 175 | 1 429 242 |
| 2013-04-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -288 | 116 286 | -0,25 | 41,94 | -12 079 | 4 876 953 |
| 2013-04-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 288 | 116 574 | 0,25 | 26,38 | 7 597 | 3 075 222 |
| 2013-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 288 | -91,24 | |||
| 2013-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 60 000 | -14,29 | |||
| 2013-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 116 286 | -7,92 | 41,06 | -410 624 | 4 774 982 |
| 2013-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 126 286 | 8,60 | 11,32 | 113 175 | 1 429 242 |
| 2013-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 116 286 | -2,51 | 41,06 | -123 187 | 4 774 982 |
| 2013-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 119 286 | 2,58 | 26,38 | 79 140 | 3 146 765 |
| 2013-02-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 3 288 | -47,71 | |||
| 2013-02-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 70 000 | -12,50 | |||
| 2013-02-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 116 286 | -7,92 | 41,96 | -419 589 | 4 879 233 |
| 2013-02-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 126 286 | 8,60 | 11,32 | 113 175 | 1 429 242 |
| 2013-02-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 116 286 | -2,51 | 41,96 | -125 877 | 4 879 233 |
| 2013-02-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 119 286 | 2,58 | 26,38 | 79 140 | 3 146 765 |
| 2013-01-08 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 6 288 | -32,30 | |||
| 2013-01-08 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 80 000 | -11,11 | |||
| 2013-01-08 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 116 286 | -7,92 | 41,47 | -414 748 | 4 822 939 |
| 2013-01-08 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 126 286 | 8,60 | 11,32 | 113 175 | 1 429 242 |
| 2013-01-08 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 116 286 | -2,51 | 41,47 | -124 424 | 4 822 939 |
| 2013-01-08 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 119 286 | 2,58 | 26,38 | 79 140 | 3 146 765 |
| 2012-12-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 9 288 | -24,41 | |||
| 2012-12-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 90 000 | -10,00 | |||
| 2012-12-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -10 000 | 116 286 | -7,92 | 40,75 | -407 491 | 4 738 550 |
| 2012-12-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 10 000 | 126 286 | 8,60 | 11,32 | 113 175 | 1 429 242 |
| 2012-12-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 116 286 | -2,51 | 40,75 | -122 247 | 4 738 550 |
| 2012-12-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 119 286 | 2,58 | 26,38 | 79 140 | 3 146 765 |
| 2012-11-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 6 144 | -19,62 | |||
| 2012-11-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 50 000 | -9,09 | |||
| 2012-11-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 58 143 | -2,51 | 81,82 | -122 737 | 4 757 528 |
| 2012-11-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 59 643 | 2,58 | 52,76 | 79 140 | 3 146 765 |
| 2012-11-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -5 000 | 58 143 | -7,92 | 81,82 | -409 123 | 4 757 528 |
| 2012-11-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 5 000 | 63 143 | 8,60 | 22,64 | 113 175 | 1 429 242 |
| 2012-11-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -534 | 58 143 | -0,91 | 76,33 | -40 762 | 4 438 206 |
| 2012-11-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -1 463 | 58 677 | -2,43 | 76,33 | -111 675 | 4 478 986 |
| 2012-10-30 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -1 284 | 60 140 | -2,09 | 78,51 | -100 807 | 4 721 591 |
| 2012-10-26 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 125 191 | 125 191 | |||||
| 2012-10-26 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
A - Award | 13 442 | 61 424 | 28,01 | ||||
| 2012-10-25 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -189 | 47 982 | -0,39 | 78,04 | -14 749 | 3 744 486 |
| 2012-10-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 7 644 | -16,40 | |||
| 2012-10-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 55 000 | -8,33 | |||
| 2012-10-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -5 000 | 48 171 | -9,40 | 80,73 | -403 630 | 3 888 657 |
| 2012-10-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 5 000 | 53 171 | 10,38 | 22,64 | 113 175 | 1 203 526 |
| 2012-10-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 48 171 | -3,02 | 80,73 | -121 089 | 3 888 657 |
| 2012-10-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 49 671 | 3,11 | 52,76 | 79 140 | 2 620 642 |
| 2012-09-06 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 9 144 | -14,09 | |||
| 2012-09-06 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 60 000 | -7,69 | |||
| 2012-09-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -5 000 | 48 171 | -9,40 | 73,67 | -368 374 | 3 548 989 |
| 2012-09-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 5 000 | 53 171 | 10,38 | 22,64 | 113 175 | 1 203 526 |
| 2012-09-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 48 171 | -3,02 | 73,70 | -110 550 | 3 550 208 |
| 2012-09-06 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 49 671 | 3,11 | 52,76 | 79 140 | 2 620 642 |
| 2012-08-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 10 644 | -12,35 | |||
| 2012-08-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 65 000 | -7,14 | |||
| 2012-08-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -5 000 | 48 171 | -9,40 | 71,68 | -358 424 | 3 453 133 |
| 2012-08-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 5 000 | 53 171 | 10,38 | 22,64 | 113 175 | 1 203 526 |
| 2012-08-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 48 171 | -3,02 | 71,92 | -107 876 | 3 464 319 |
| 2012-08-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 49 671 | 3,11 | 52,76 | 79 140 | 2 620 642 |
| 2012-07-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 12 144 | -10,99 | 74,01 | -111 015 | 898 777 |
| 2012-07-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 70 000 | -4,11 | 74,02 | -222 048 | 5 181 127 |
| 2012-07-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 171 | -5,86 | 74,02 | -222 048 | 3 565 430 |
| 2012-07-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 171 | 6,23 | 22,64 | 67 905 | 1 158 256 |
| 2012-07-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 48 171 | -3,02 | 74,01 | -111 015 | 3 565 136 |
| 2012-07-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 49 671 | 3,11 | 52,76 | 79 140 | 2 620 642 |
| 2012-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 13 644 | -9,90 | 68,59 | -102 882 | 935 815 |
| 2012-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 73 000 | -3,95 | 68,47 | -205 412 | 4 998 346 |
| 2012-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 171 | -5,86 | 68,47 | -205 412 | 3 298 292 |
| 2012-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 171 | 6,23 | 22,64 | 67 905 | 1 158 256 |
| 2012-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 48 171 | -3,02 | 68,59 | -102 882 | 3 303 953 |
| 2012-06-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 49 671 | 3,11 | 52,76 | 79 140 | 2 620 642 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 500 | 15 144 | -9,01 | 71,63 | -107 439 | 1 084 704 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 0 | -100,00 | 71,79 | -143 586 | |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 76 000 | -3,80 | 71,71 | -215 143 | 5 450 279 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 171 | -5,86 | 71,71 | -215 143 | 3 454 545 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 171 | 6,23 | 22,64 | 67 905 | 1 158 256 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -2 000 | 48 171 | -3,99 | 71,79 | -143 586 | 3 458 341 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 2 000 | 50 171 | 4,15 | 41,15 | 82 300 | 2 064 537 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -1 500 | 48 171 | -3,02 | 71,63 | -107 439 | 3 450 296 |
| 2012-05-03 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 1 500 | 49 671 | 3,11 | 52,76 | 79 140 | 2 620 642 |
| 2012-04-09 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
D - Sale to Issuer | X | -167 | 48 171 | -0,35 | 69,69 | -11 638 | 3 356 984 |
| 2012-04-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 2 000 | -50,00 | 69,76 | -139 521 | 139 521 |
| 2012-04-04 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 79 000 | -3,66 | 69,81 | -209 426 | 5 514 887 |
| 2012-04-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 338 | -5,84 | 69,81 | -209 426 | 3 374 413 |
| 2012-04-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 338 | 6,21 | 22,64 | 67 905 | 1 162 036 |
| 2012-04-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -2 000 | 48 338 | -3,97 | 69,76 | -139 521 | 3 372 083 |
| 2012-04-04 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 2 000 | 50 338 | 4,14 | 41,15 | 82 300 | 2 071 409 |
| 2012-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 4 000 | -33,33 | 65,80 | -131 600 | 263 200 |
| 2012-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 82 000 | -3,53 | 65,80 | -197 400 | 5 395 600 |
| 2012-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 338 | -5,84 | 65,80 | -197 400 | 3 180 640 |
| 2012-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 338 | 6,21 | 22,64 | 67 905 | 1 162 036 |
| 2012-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -2 000 | 48 338 | -3,97 | 65,80 | -131 600 | 3 180 640 |
| 2012-03-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 2 000 | 50 338 | 4,14 | 41,15 | 82 300 | 2 071 409 |
| 2012-02-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 6 000 | -25,00 | 65,06 | -130 120 | 390 360 |
| 2012-02-02 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 85 000 | -3,41 | 65,06 | -195 180 | 5 530 100 |
| 2012-02-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 338 | -5,84 | 65,06 | -195 180 | 3 144 870 |
| 2012-02-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 338 | 6,21 | 22,64 | 67 905 | 1 162 036 |
| 2012-02-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -2 000 | 48 338 | -3,97 | 65,06 | -130 120 | 3 144 870 |
| 2012-02-02 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 2 000 | 50 338 | 4,14 | 41,15 | 82 300 | 2 071 409 |
| 2012-01-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 8 000 | -20,00 | 62,49 | -124 976 | 499 902 |
| 2012-01-05 |
|
4 | HAE |
HAEMONETICS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 88 000 | -3,30 | 62,49 | -187 463 | 5 498 926 |
| 2012-01-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -3 000 | 48 338 | -5,84 | 62,49 | -187 463 | 3 020 535 |
| 2012-01-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 3 000 | 51 338 | 6,21 | 22,64 | 67 905 | 1 162 036 |
| 2012-01-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
S - Sale | X | -2 000 | 48 338 | -3,97 | 62,49 | -124 976 | 3 020 535 |
| 2012-01-05 |
|
4 | HAE |
HAEMONETICS CORP
Common Stock |
M - Exercise | X | 2 000 | 50 338 | 4,14 | 41,15 | 82 300 | 2 071 409 |
